liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Linking immunity to atherosclerosis: Implications for vascular pharmacology - A tribute to Goran K. Hansson
University of Texas Houston.
Linköping University, Department of Medical and Health Sciences, Cardiology. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Heart and Medicine Centre, Department of Cardiology UHL.
2012 (English)In: Vascular pharmacology, ISSN 1537-1891, E-ISSN 1879-3649, Vol. 56, no 1-2, 29-33 p.Article, review/survey (Refereed) Published
Abstract [en]

For the past decade, we have deepened our understanding of the pathogenesis of atherosclerosis, a chronic arterial disease that causes cardiac and cerebral infarction and peripheral vascular disorders. Because of this extended understanding, more effective strategies for prevention and treatment of this disease are emerging. One of the fundamental mechanisms that lead to progress or regression in atherosclerosis, thus influencing its life-threatening complications, occurs through functional changes in vascular immunity and inflammation. This review briefly summarizes the discoveries in basic and translational sciences in this area and recent advances in clinical medicine against atherosclerotic vascular diseases.

Place, publisher, year, edition, pages
Elsevier , 2012. Vol. 56, no 1-2, 29-33 p.
Keyword [en]
Atherosclerosis, Immunity, Inflammation, Macrophages, Lymphocytes, Antibody, Immunotherapy
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-75473DOI: 10.1016/j.vph.2011.11.001ISI: 000300121400005OAI: oai:DiVA.org:liu-75473DiVA: diva2:507078
Note
Funding Agencies|National Institutes of Health||Texas State Higher Education Board||Swedish Research Council||Swedish Heart-Lung Foundation||Available from: 2012-03-02 Created: 2012-03-02 Last updated: 2017-12-07

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Jonasson, Lena

Search in DiVA

By author/editor
Jonasson, Lena
By organisation
CardiologyFaculty of Health SciencesDepartment of Cardiology UHL
In the same journal
Vascular pharmacology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 84 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf